The company provides personalized treatment solutions for chronic mental health disorders like depression, anxiety, and PTSD, using evidence-based therapeutics and technologies such as Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. Through teletherapy and interventional treatments, Heading Health aims to improve access to effective and affordable mental health care, supporting patients to achieve mental well-being.